Kit ELISA sandwich Vascular Endothelial Growth Factor D (Hu VEGFD/FIGF) (human): quantitative determination of Hu VEGFD in serum, plasma or cell culture medium.
Kit ELISA sandwich Vascular Endothelial Growth Factor D (Hu VEGFD/FIGF) (human): quantitative determination of Hu VEGFD in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu VEGFD.
Method principle: This ELISA solid phase sandwich test (immuno-enzymatic dose) measures the amount of target bound between a pair of matched antibodies. A specific target antibody is pre-adsorbed into the wells of the supplied microplate. Samples, standards or controls are added to these wells and bind to immobilized antibodies (capture antibodies). The sandwich is formed by adding the second antibody (detection antibody), then a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this signal is directly proportional to the concentration of the target present in the original sample.
Rigorous validation: Each batch manufactured from this ELISA kit is checked for criteria such as sensitivity, specificity, accuracy and reproducibility from one batch to another (see the package leaflet for more information on validation).
VEGF has been identified in several forms, including VEGF, VEGF-B, VEGF-C and VEGF-D (also known as FIGF). The central region of VEGF-D contains eight cysteine residues, characteristic of VEGF proteins. These residues are essential to homodimerization. VEGFD can play a role in tumour progression, as it is induced by c-Fos, which is necessary for the conversion of early tumours to malignancies. Overexpression of VEGF-D has been observed to induce morphological changes in fibroblasts.
Sensitivity
Sensitivity of dosage: 0.2 ng/ml.
Measurement range
Dose range: 0.313 ng/ml to 20 ng/ml.
Duration of dosing
Total dosage duration: 4 hours 45 min.
Samples
Sample type: Plasma, Serum, Surnatant (plasma volume, 50 μl; serum, 50 μl; supernatant, 100 μl).
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 17115449 |
| Specifications |
| Accession number | O43915 |
| Dose range | 0.313 ng/ml to 20 ng/ml |
| Sensitivity of the dosage | 0.2 ng/ml |
| Calibration range | 0.2 ng/ml to 20 ng/ml |
| Dose | ELISA solid-phase sandwich |
| Conjugate | Biotin |
| Product type | Kit ELISA |
| Protein family | Chemiokine & receptors |
| Type of sample | Plasma, Serum, Surnatant |
| Specificity | This ELISA kit shows no cross-reactivity with the following tested cytokines: human angiogenin, BDNF, BLC, CNTF, ENA-78, FGF-4, IL-1 alpha, IL-1 beta, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-11, IL-12 p70, IL-12 p40, IL-13, IL-15, IL-309, IP-10, FGF-4, FGF-6, FGF-7, G-CSF, GD |
| Sufficient for | 5 x 96 dosages |
| Target species | Human |
| For use with (application) | ELISA, protein dosage, protein biology, cancerology, immunology, neuroscience, neurobiology, protein detection, protein analyses |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | 2277 |
| Gene symbol(s) | FIGF,VEGF-D |
| Coefficient of inter-dose variation | <12% |
| Coefficient of intra-dose variation | <10% |
| Contents of kits | Chromogen, Biotinylated Detection Antibody, Dosing Diluent Concentrate, 96-well pre-coated plates, Stalcon, Stop solution, Wash pad, SAV-HRP, Adhesive plate covers |
| Marker or dye | HRP |
| Quantity | 5 x 96 tests |
| Regulatory status | RUO |
| Research disciplines | Immunology |
| Synonym | VEGF-D, VEGFD |
| Target | Human |
| Test time | 1 hour 20 minutes. |
| Physical characteristics |
| Volume of sample | Plasma, 50 μl; serum, 50 μl; supernatant, 100 μl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 4:45 a.m. |
Origin and customs
| Manufacturer ref. | EHFIGFX5 |
|---|
| Country of origin | United States |
|---|
A question or a specific configuration?
Contact us for a quote.